Recent studies [46] have shown that Hmgcs2 is upregulated in expression in NAFLD mouse models, while Hmgcs2 deficiency and inhibitors promote ketogenesis in NAFLD mice and palmitate induced HepG2, attenuate hepatocyte injury and inflammation due to lipotoxicity. This evidence concerns the gene HMGCS2 and metabolic dysfunction-associated steatotic liver disease.